Register entry

Winthrop U.S, a business of sanofi-aventis U.S. LLC

Data as of · How to read this entry

Registered sites
0
Active NDC listings
2
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 human prescription drug. By marketing category: NDA AUTHORIZED GENERIC 2.

Dosage formNDCs
injection, solution, concentrate2
RouteNDCs
intravenous2
Labeller name on the listingNDCs
winthrop u.s, a business of sanofi-aventis u.s. llc2
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
OXALIPLATINoxaliplatininjection, solution, concentrate, intravenous0955-1731NDA AUTHORIZED GENERIC
OXALIPLATINoxaliplatininjection, solution, concentrate, intravenous0955-1733NDA AUTHORIZED GENERIC
Compare

Other companies listing oxaliplatin

Enquiry

Common questions

Is Winthrop U.S, a business of sanofi-aventis U.S. LLC FDA approved?
Winthrop U.S, a business of sanofi-aventis U.S. LLC holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Winthrop U.S, a business of sanofi-aventis U.S. LLC make?
2 products are listed under Winthrop U.S, a business of sanofi-aventis U.S. LLC in the openFDA NDC Directory, most often as injection, solution, concentrate. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.